The lab panels for evaluating a patient with arthralgias/arthritis for lupus or connective tissue disease are costly. Once a complete blood count and erythrocyte sedimentation rate have been done, is ...
Recent research from the Medical University of South Carolina laboratory of Russell Norris, Ph.D., challenges the notion that ...
Please provide your email address to receive an email when new articles are posted on . One out of three registered randomized controlled trials on connective tissue diseases are never completed or ...
EULAR—The European Alliance of Associations for Rheumatology—has worked with the European Respiratory Society (ERS) to develop new clinical practice guidelines for interstitial lung disease (ILD) ...
A retrospective cohort study found that most connective tissue diseases (CTDs) and select neutrophilic dermatoses were associated with significantly increased 1‑, 5‑, and 10‑year risks for hematologic ...
Interstitial lung disease (ILD) causes significant morbidity and mortality in patients with systemic autoimmune rheumatic diseases. Patients at high risk of ILD should be screened using ...
PHILADELPHIA -- Rituximab (Rituxan) matched IV cyclophosphamide for improving lung function in patients with interstitial lung disease (ILD) related to systemic sclerosis and other connective tissue ...
Patients with both systemic sclerosis (SSc) and systemic lupus erythematosus (SLE) are more likely to be female, Black, and diagnosed with limited cutaneous SSc. Researchers used the 2019 SLE ...
For connective tissue diseases, the multiplex assay is designed to rapidly detect and identify up to 1275 disease markers per hour. Seamless, microarray-internal calibration and quality control as ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback